ARCHIVES

Clinical Trials Approved By NCI Listed For September

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

ANG1005 Demonstrates Activity In Patients with Brain Metastases

November 29, 2013

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Too Few Minority Scientists Enter Careers In Public Health, Oncology, Bynum Reports

March 24, 1989

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Funding opportunities listed.

April 16, 2004

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978